Minimally Invasive Surgery for Liver Cancer
Washington, DC - For patients who may benefit from a major liver operation to treat cancer, an open abdominal procedure is often the only option. However, a minimally invasive approach that avoids the large open incision may soon be a viable alternative, according to results from a multicenter study presented at the 2016 Clinical Congress of the American College of Surgeons (ACS).
The researchers evaluated 1,015 major liver resections (hepatectomies) performed in 2014 at 65 hospitals that participate in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) Hepatopancreaticobiliary Collaborative. Of those procedures, 13 percent, or 132, were performed using minimally invasive surgery (MIS), the rest were performed using open operations. This research is the largest multicenter study to date evaluating outcomes after MIS major liver resection.
“Major hepatectomy is a high-risk procedure used to remove approximately half of a patient's liver and is the treatment of choice for many cancers involving the liver,” according to lead investigator Lucas W. Thornblade, MD, a general surgery resident at the University of Washington, Seattle. “Our study results showed that the odds of serious morbidity, including major bleeding, serious infections, organ failure, and death, were significantly lower after major liver resection performed by MIS.”
In this study, the odds of death or serious complications in the short term for liver cancer patients who had MIS was about half that of those who had the conventional open procedure. Risk of bile leak, liver failure, a second operation, or readmission were similar between the two types of operations. Continue>
Posted in: Procedures | January 10, 2017
Posted in: Procedures | August 12, 2013
Posted in: Procedures | March 20, 2014